The invention relates generally to naphthyridine derivatives of the formula wherein one of U, X, Y and Z is nitrogen and the others are C-R, where R is hydrogen or a substituent. More specifically, the invention relates to 1,8-naphthyridine derivatives and pharmaceutical compositions containing such derivatives. Methods of the invention comprise administration of a naphthyridine derivative of the invention for the treatment of diabetes and related disorders.
本发明涉及公式的
萘啶衍
生物,其中U、X、Y和Z中的一个是氮,其余为C-R,其中R是氢或取代基。更具体地,本发明涉及
1,8-萘啶衍
生物和含有这种衍
生物的药物组合物。本发明的方法包括给予本发明的
萘啶衍
生物治疗糖尿病及相关疾病。